Navigation Links
Tengion Provides Update on Neo-Urinary Conduit Clinical Trial
Date:6/13/2011

Augment; (ii) expectations regarding the initial clinical trial of the Neo-Urinary Conduit and (iii) expectations regarding planned preclinical studies of the Neo-Kidney Augment. Although Tengion believes that these statements are based upon reasonable assumptions within the bounds of its knowledge of its business and operations, there are a number of factors that may cause actual results to differ from these statements. For instance there can be no assurance that: (i) the Company's Neo-Urinary Conduit clinical trial will not be placed on clinical hold by the Food and Drug Administration, or FDA; (ii) patients enrolled in the Company's Neo-Urinary Conduit clinical trial will not experience additional adverse events, which could delay clinical trials or cause the Company to terminate the development of the Neo-Urinary Conduit; (iii) the Company will be able to successfully enroll patients in its clinical trials, including its initial clinical trial for the Neo-Urinary Conduit; (iv) the results of the clinical trial for the Neo-Urinary Conduit will support further development of that product candidate; (v) data from the Company's ongoing preclinical studies will continue to be supportive of advancing its preclinical product candidates; and (vi) the Company will be able to progress its product candidates that are undergoing preclinical testing, including the Neo-Kidney Augment, into clinical trial and (vii) the Company will be able to obtain the capital it needs to develop its product candidates and continue its operations.  For additional factors which could cause actual results to differ from expectations, reference is made to the reports filed by the Company with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended.  The forward looking statements in this release are made only as of the date hereof and the Company disclaims any intention or responsibility for updating predictions or expectations in this rele
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tengion Announces FDA Orphan-Drug Designation for Neo-Urinary Conduit
2. Tengion Presents New Data in Nine Posters and Two Oral Presentations at TERMIS North America Annual Meeting
3. Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients
4. Tengion Provides Business Update and Reports Third Quarter 2010 Financial Results
5. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
6. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
7. Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
8. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
9. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
10. Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM)
11. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015  Game-changing ... the latest being the European Commission,s ruling on ... global leader and champion of pharmaceutical supply ... of meeting these mandates and offers several tools ... many countries. From an upcoming webinar in May ...
(Date:4/21/2015)...  IntelliQuit™, the world,s first smartphone breathalyzer for smokers, was selected to present as a finalist ... City on Wednesday April 22.  ... ... ... Thirty percent (30%) of all cardiovascular disease is caused by smoking. ...
(Date:4/21/2015)... , April 21, 2015  The American ... U.S. Food and Drug Administration that the agency,s ... for the last 25 years to protect the ... homeopathic medicines. AAHP, the industry,s trade association, was ... of homeopathic medicines to engage in productive discussions ...
Breaking Medicine Technology:Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 2Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 3IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 2IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 3Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework 2
... CoMeD – On Friday, May 6, 2011, in Tallahassee, ... regulate vaccines containing mercury in Florida.  The amendment would ... import, administer or distribute any vaccine that contained more ... milliliter for children younger than age 7 or pregnant ...
... BEIJING, May 9, 2011 Saladax Biomedical, Inc., a ... to achieve the promise of personalized medicine for new ... Pacific Rim commercialization team to expand its presence in ... Rim commercialization team include: Yunying ...
Cached Medicine Technology:Florida Legislature Refuses to Limit Mercury in Vaccines 2Florida Legislature Refuses to Limit Mercury in Vaccines 3Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China 2
(Date:4/21/2015)... Top medical tourism firm, VisitandCare.com, is ... ongoing commitment to providing superior patient experiences. Ojas ... with the best possible experience for a comprehensive range ... , Executives at Ojas Aesthetic Clinic persistently assert that, ... nothing about you, without you — through transparent engagement ...
(Date:4/21/2015)... Angelo’s FabriClean has recently announced that the company ... avail the area rug cleaning services. Area rug cleaning ... equipments, making use of the quick drying technique to ... pressure steam extraction to clean even the most stubborn ... made with delicate fabric. , “Good maintenance and ...
(Date:4/21/2015)... Somerset, NJ & New York, NY (PRWEB) April ... the leading global provider of advanced delivery technologies ... health products, today announced the launch of ADVASEPT™ ... the safe and efficient delivery of injectable medications. ... syringe, combining a safe, convenient and functional container ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 QuickMedical, ... equipment and supplies, now represents Schiller America's ... Monitors, ECGs, Stress Tests, and Vital Signs Monitors, ... in Switzerland, is a global leader in the ... products are developed in close cooperation with the ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 21, 2015 ... Global Sodium Citrate Industry is a professional and ... global Sodium Citrate Market with a ... companies included in the sodium citrate market research ... Acid Chemicals, Natural Biological, Cofco Biochemical, Capchem, Lianyungang ...
Breaking Medicine News(10 mins):Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 2Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 3Health News:Angelo’s FabriClean Now Offers Area Rug Cleaning in South Surrey with Complimentary Pick-Up and Delivery 2Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3
... phase of the illness, study says , , WEDNESDAY, Sept. 12 ... the manic phase of bipolar disorder, and works faster than ... a new study has found. , "One of the problems ... have this long period before they start to work," explained ...
... Chance to Help Make a Difference & Join ... N.C., Sept. 12 This fall, Pink is the color,of ... its,14th anniversary in the battle against Breast Cancer September 20 ... to save lives by,purchasing a new 25% Pink Savings Card. ...
... CDH plans continue to grow in popularity among ... Employees who fear high,out-of-pocket costs aren,t blocking the ... and employers take advantage of,money-saving options as healthcare ... Consulting Worldwide, the global human capital consulting,organization of ...
... prevailing issue in the United States, with millions of ... that Pycnogenol, (pic-noj-en-all), an antioxidant plant extract from the ... in children. The study shows Pycnogenol balances stress hormones, ... of ADHD. , The findings, to be published ...
... the days of Hippocrates, people have known that certain ... researchers have learned that these cyclic recurrences of disease, ... In order to accurately predict when outbreaks of disease ... Elena Naumova, PhD, associate professor in the Department of ...
... LOS GATOS, Calif., Sept. 12 Death may be the ... about. It is usually looked,upon as something to fear -- ... Darlyne intend to tear down the walls. "Triumph" is ... Philip,and Darlyne clarified and expressed their feelings about Darlyne,s,impending death ...
Cached Medicine News:Health News:Tamoxifen Helps Treat Bipolar Disorder 2Health News:Tamoxifen Helps Treat Bipolar Disorder 3Health News:Photo: Tanger Outlet Center Shoppers Nationwide can Choose Pink to Fight Breast Cancer 2Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 2Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 3Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 4Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 5Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 6Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 7Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 8Health News:New study: Pine bark extract reduces ADHD symptoms in children 2Health News:Mathematics might save you a trip to the ER 2Health News:'Triumph' -- Traveling Towards Death: Preparing for a New Life 2
Chin Implants are used for cosmetic augmentation, repairing trauma related injuries and genetic deficiencies. They are inserted through an incision in the mouth below the incisor teeth or through an ...
... The IEC CL40 and FL40 Centrifuge ... safety and versatility to increase your ... a broad array of rotors and ... and microplate applications, the IEC CL40 ...
... CL40 and FL40 Centrifuge Series from ... versatility to increase your productivity in ... array of rotors and accessories for ... applications, the IEC CL40 and FL40 ...
... IEC CL31 Multispeed Series offers unsurpassed ... quiet, compact, 1.2 liter benchtop centrifuge. ... and accessories and high-speed centrifugation capabilities, ... everything you need to meet a ...
Medicine Products: